A 65-year-old man was hospitalized in our department with generalized lymphadenopathy. He was diagnosed with mantle cell lymphoma (MCL) complicated by peripheral tumorigenesis and marrow infiltration in a biopsy of cervical lymph nodes. Upper gastrointestinal endoscopy showed multiple tuberous lesions in the lower esophagus (• " Fig. 1 ) and the great curvature of the stomach (• " Fig. 2 a) . These findings were diagnosed as multiple lymphomatous polyposis (MLP). Narrow-band imaging (NBI) with magnification showed microscopically dendritic abnormal vascular hyperplasia on tuberous parts of intragastric MLP lesions (• " Fig. 2 b) . Lower gastrointestinal endoscopy showed a tuberous lesion in the cecum (• " Fig.3 a) and multiple small polypoid lesions throughout the large intestine (• " Fig. 3 b) . Immunohistologic staining of biopsy tissues from the stomach (• " Fig.4 a -d ) and large intestine (• " Fig. 5 a -d) gave positive results for CD5, CD20, and cyclin D1 colocalized with nuclear staining. These findings permitted a definite diagnosis of gastrointestinal lesions of MCL. Treatment is planned with R-hyper CVAD/MA followed by high dose chemotherapy combined with autologous peripheral blood stem cell transplantation.
MCL is a B-cell lymphoma that accounts for 5 % -10 % of cases of malignant lymphoma, and 75 % of cases of MCL at diagnosis are at an advanced stage (III or IV) [1] . Extranodal infiltration is found most frequently in the gastrointestinal tract, but 5.7 % of cases show extranodal infiltration in esophageal lesions [2] . There are a few reports of narrow-band imaging with magnifying endoscopy for gastrointestinal lesions of MCL, and this technique has been described in a few cases of dendritic abnormal vascular hyperplasia [3] . High dose chemotherapy combined with autologous peripheral blood stem cell transplantation after R-hyper CVAD/MA treatment is effective for advanced MCL [4] . A combination of rituximab and bendamustine as intensive chemotherapy may also be useful for cases that are difficult to treat [5] .
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